SEARCH

SEARCH BY CITATION

References

  • Adhikari, R.P., Karauzum, H., Sarwar, J., Abaandou, L., Mahmoudieh, M., Boroun, A.R., Vu, H., Nguyen, T. et al. (2012) Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia. PLoS One 7, 38567.
  • Burnside, K., Lembo, A., de Los Reyes, M., Iliuk, A., Binhtran, N.T., Connelly, J.E., Lin, W.J., Schmidt, B.Z. et al. (2010) Regulation of Hemolysin Expression and Virulence of Staphylococcus aureus by a Serine/Threonine Kinase and Phosphatase. PLoS One 5, e11071.
  • Calderone, V., Chericoni, S., Martinelli, C., Testai, L., Nardi, A., Morelli, I., Breschi, M.C. and Martinotti, E. (2004) Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn-Schmiedeberg's Arch Pharmacol 370, 290298.
  • Capparelli, R., Nocerino, N., Medaglia, C., Blaiotta, G., Bonelli, P. and Iannelli, D. (2011) The Staphylococcus aureus Peptidoglycan Protects Mice against the Pathogen and Eradicates Experimentally Induced Infection. PLoS One 6, e28377.
  • Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement. CLSI/ NCCLS document M100-S15. Clinical and Laboratory Standards Institute (CLSI). Wayne, PA.
  • DeLeo, F.R. and Otto, M. (2008) An antidote for Staphylococcus aureus pneumonia? J Exp Med 205, 271274.
  • Erejuwa, O.O., Sulaiman, S.A. and Ab Wahab, M.S. (2012) Honey - A Novel Antidiabetic Agent. Int J Biol Sci 8, 913934.
  • Fritsche, T.R., Sader, H.S. and Jones, R.N. (2008) Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogen: SENTRY Antimicrobial Surveillance results from the Program (2005–2006). Diagn Microbiol Infect Dis 61, 8695.
  • Gao, M., Zhang, W.C., Liu, Q.S., Hu, J.J., Liu, G.T. and Du, G.H. (2008) Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur J Pharmacol 591, 7379.
  • Gordon, R.J. and Lowy, F.D. (2008) Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection. Clin Infect Dis 46, S350S359.
  • Guang, H.M. and Du, G.H. (2006) Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats. Eur J Pharmacol 542, 7783.
  • Hanasaki, Y., Ogawa, S. and Fukui, S. (1994) The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16, 845850.
  • Herbert, S., Barry, P. and Novick, R.P. (2001) Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 69, 29963003.
  • Koyama, N., Tokura, Y., Takahashi, Y. and Tomoda, H. (2011) New cyslabdans B and C, potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus produced by Streptomyces sp. K04–0144. Acta Pharmacol Sin B 1, 236239.
  • Kuehnert, M.J., Hill, H.A., Kupronis, B.A., Tokars, J.I., Solomon, S.L. and Jernigan, D.B. (2005) Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States. Emerg Infect Dis 11, 468872.
  • Leng, B.F., Qiu, J.Z., Dai, X.H., Dong, J., Wang, J.F., Luo, M.J., Li, H.E., Niu, X.D. et al. (2011) Allicin reduces the production of α-toxin by Staphylococcus aureus. Molecules 16, 79587968.
  • Liu, R., Gao, M., Yang, Z.H. and Du, G.H. (2008) Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro. Brain Res 1216, 104115.
  • Manna, A.C. and Cheung, A.L. (2006) Expression of SarX, a negative regulator of agr and exoprotein synthesis, Is activated by MgrA in Staphylococcus aureus. J Bacteriol 188, 42884299.
  • Niederman, M.S. (2009) Treatment options for nosocomial pneumonia due to MRSA. J Infect 59, 2531.
  • Novick, R.P. and Geisinger, E. (2008) Quorum Sensing in Staphylococci. Annu Rev Genet 42, 541564.
  • OIE International Committee (2007) OIE List of Antimicrobials of Veterinary Importance its 75th General Session in May (Resolution No. XXVIII).
  • Pang, Y.Y., Schwartz, J., Thoendel, M., Ackermann, L.W., Horswill, A.R. and Nauseef, W.M. (2010) AgrDependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2, 546559.
  • Powers, M.E., Kim, H.K., Wang, Y. and Wardenburg, J.B. (2012) ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J Infect Dis 206, 352356.
  • Prince, L.R., Graham, K.J., Connolly, J., Anwar, S., Ridley, R., Sabroe, I., Foster, S.J. and Whyte, M.K. (2012) Staphylococcus aureus induces eosinophil cell death mediated by α-hemolysin. PLoS One 7, e31506.
  • Qiu, J., Wang, J., Luo, H., Du, X., Li, H., Luo, M., Dong, J., Chen, Z. et al. (2010a) The effects of subinhibitory concentrations of costus oil on virulence factor production in Staphylococcus aureus. Lett Appl Microbiol 110, 333340.
  • Qiu, J., Jiang, Y., Xia, L., Xiang, H., Feng, H., Pu, S., Huang, N., Yu, L. et al. (2010b) Subinhibitory concentrations of licochalcone A decrease alpha-toxin production in both methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Lett Appl Microbiol 50, 223229.
  • Qiu, J., Xiang, H., Hu, C., Wang, Q., Dong, J., Li, H., Luo, M., Wang, J. et al. (2011a) Subinhibitory concentrations of farrerol reduce a-toxin expression in Staphylococcus aureus. FEMS Microbiol Lett 315, 129133.
  • Qiu, J., Li, H., Meng, H., Hu, C., Li, J., Luo, M., Dong, J., Wang, X. et al. (2011b) Impact of luteolin on the production of alpha-toxin by Staphylococcus aureus. Lett Appl Microbiol 53, 238243.
  • Ragle, B.E., Karginov, V.A. and Wardenburg, J.B. (2010) Prevention and treatment of Staphylococcus aureus pneumonia with a β-cyclodextrin. Antimicrob Agents Chemother 54, 298304.
  • Seidl, K., Bayer, A.S., McKinnell, J.A., Ellison, S., Filler, S.G. and Xiong, Y.Q. (2011) In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin resistant Staphylococcus aureus. Cell Microbiol 13, 15301541.
  • Soromou, L.W., Chu, X., Jiang, L., Wei, M., Huo, M., Chen, N., Guan, S., Yang, X. et al. (2012) In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. Int Immunopharmacol 14, 6674.
  • Touil, Y.S., Fellous, A., Scherman, D. and Chabot, G.G. (2009) Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization. Nutr Cancer 61, 310321.
  • Wardenburg, J.B. and Schneewind, O. (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205, 287294.
  • Welte, T. and Pletz, M.W. (2010) Antimicrobial treatment of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Int J Antimicrob Agents 36, 391400.
  • Wilke, G.A. and Wardenburg, J.B. (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 107, 1347313478.
  • Wu, H.J., Wang, A.H. and Jennings, M.P. (2008) Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol 12, 93101.